Clearline Capital LP - Dec 31, 2024 Form SCHEDULE 13G Schedule Report for TherapeuticsMD, Inc. (TXMD)

Filing Manager: Clearline Capital LP
Reporting Manager: Clearline Capital LP
Security: TherapeuticsMD, Inc. Common Stock, par value $0.001 per share
Symbol: TXMD
Shares outstanding: 11.5M shares
Disclosed Ownership: 635K shares
Ownership: 5.5%
Form type: SCHEDULE 13G
Date filed: 2/12/2025, 04:25 PM
Date of event: Dec 31, 2024
SEC: View on sec.gov

Reporting Managers (3)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Clearline Capital LP	5.5%	635K	0	635K	Marc Majzner	Limited Partner
Clearline Capital, LLC	5.5%	635K	0	635K	Marc Majzner	Managing Member
Marc Majzner	5.5%	635K	0	635K	Marc Majzner	Authorized Signatory